- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 1 Gaucher Disease in Ireland
Total 1546 results
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States, Israel
-
National Cancer Institute (NCI)CompletedExtensive Stage Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States
-
Lucid Diagnostics, Inc.RecruitingBarrett Esophagus | Esophageal Adenocarcinoma | Barrett's Esophagus Without Dysplasia | Barretts Esophagus With DysplasiaUnited States, Netherlands
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, France, Korea, Republic of, Canada, Belgium, New Zealand, Russian Federation
-
Spectrum Pharmaceuticals, IncBayerTerminatedLymphoma, Large Cell, DiffuseSweden, United States, Italy, Korea, Republic of, Spain, United Kingdom, Hungary, Poland, Finland, Canada, France, Germany, Portugal, Thailand, Belgium, Austria, Ireland, Singapore, Switzerland
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Sarcoma | Uterine CarcinosarcomaUnited States
-
Mannkind CorporationCompletedDiabetes, Type IUnited States, Spain, Brazil, Argentina, Canada, Chile, Mexico, Poland, Russian Federation, United Kingdom
-
Hoffmann-La RocheRecruitingNon-Hodgkin LymphomaUnited States, Korea, Republic of, China, Mexico, Japan, Brazil, Argentina, Thailand, Canada, Peru, Turkey, Russian Federation, Israel, New Zealand
-
National Cancer Institute (NCI)RecruitingPrimary Diffuse Large B-Cell Lymphoma of the Central Nervous SystemUnited States
-
Seagen Inc.TerminatedFollicular B-cell Non-Hodgkin's Lymphoma | Diffuse Large B-cell Lymphoma RefractoryUnited States, Italy, Spain, United Kingdom, Czechia, Poland, France
-
Trans Tasman Radiation Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical... and other collaboratorsActive, not recruitingCarcinoma, Ductal, BreastUnited Kingdom, Netherlands, Ireland, Switzerland, Australia, Singapore, New Zealand, Belgium, Canada, Italy, France
-
Eli Lilly and CompanyCompletedOvarian CancerUnited States, Israel, Spain, Korea, Republic of, Australia, Belgium, United Kingdom, Italy
-
BeiGeneRecruitingMarginal Zone Lymphoma | Relapsed/Refractory Follicular LymphomaUnited States, Italy, Spain, China, United Kingdom, Australia, Israel, Korea, Republic of, Belgium, France, Brazil, Ireland, Czechia, Romania, Portugal, Georgia, Argentina, Poland, Puerto Rico, Austria, Switzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, India, Italy, Mexico, Russian Federation, United Kingdom, Spain, Malaysia, Croatia, Greece, Korea, Republic of, Japan, South Africa, Algeria, Thailand, Argentina, Brazil, Canada, Romania
-
National Cancer Institute (NCI)Active, not recruitingGlioblastoma | GliosarcomaUnited States, Puerto Rico
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Terminated
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Hoffmann-La RocheCompletedChronic Lymphocytic LeukemiaItaly, Sweden, Belgium, Brazil, Canada, Germany, Ireland, Korea, Republic of, Spain, Russian Federation, France, Finland, Israel, Estonia, Romania, Egypt, Thailand, Switzerland, Bosnia and Herzegovina, Slovakia, Turkey, Lithuania, P... and more
-
National Cancer Institute (NCI)RecruitingNasopharyngeal Carcinoma | Stage IV Nasopharyngeal Carcinoma AJCC v8United States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, Puerto Rico, Netherlands
-
Laekna LimitedActive, not recruitingPlatinum-resistant Ovarian CancerUnited States, China
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedAdult MeningiomaUnited States
-
Hoffmann-La RocheCompletedMelanomaUnited States, Israel, Italy, Spain, Belgium, United Kingdom, Austria, Czechia, France, Netherlands, New Zealand, Russian Federation, Australia, Canada, Croatia, Portugal, Germany, Ukraine, Switzerland, Argentina, Brazil, Ireland, N... and more
-
National Cancer Institute (NCI)TerminatedBreast Carcinoma | Stage IV Breast Cancer | Recurrent Breast CarcinomaUnited States
-
Eli Lilly and CompanyRecruitingCardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or ObesityUnited States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Romania, Brazil, Czechia, Germany, Mexico, Argentina, Greece, Slovakia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, Puerto Rico, Netherlands
-
National Cancer Institute (NCI)Active, not recruitingPRETEXT I Hepatoblastoma | PRETEXT II Hepatoblastoma | PRETEXT III Hepatoblastoma | PRETEXT IV HepatoblastomaUnited States, Canada, Puerto Rico, Australia, Japan, Brazil
-
Incyte CorporationChildren's Oncology GroupActive, not recruitingLeukemiaUnited States, Canada, Puerto Rico
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Spain, United Kingdom
-
ImmunoGen, Inc.Gynecologic Oncology GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France, Canada, Spain, Switzerland, Belgium, Italy, United Kingdom, Ireland, Russian Federation, Bosnia and Herzegovina, Czechia, Serbia
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Israel
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, Poland, Ukraine, Germany, Spain, Turkey, Korea, Republic of, Brazil, Russian Federation, Netherlands, Hungary, Sweden, Czechia, Mexico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMalignant MesotheliomaUnited States
-
Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaUnited States, United Kingdom, Australia, Israel, Canada, Belgium, Austria, Czechia, Serbia, India, France, Italy, Russian Federation, Bulgaria, Germany, Greece, Hungary, Poland, Romania, Spain, Ukraine
-
AstraZenecaCompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Canada
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Belgium, Canada, China, Czechia, Ireland, Israel, Italy, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
Unither PharmaceuticalsTerminated
-
National Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Canada
-
NovoCure GmbHActive, not recruitingGlioblastoma MultiformeUnited States, United Kingdom, Israel, Germany, Japan, Canada, France, Switzerland, Belgium, Czechia, Austria
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Persistent DiseaseUnited States
-
Regeneron PharmaceuticalsRecruitingMelanomaUnited States, Spain, Germany, Mexico, Turkey, Canada, Austria, Netherlands, United Kingdom, Italy, Georgia, France, Brazil, Romania, Czechia, Argentina, Australia, Ireland, Chile, Hungary, South Africa, Belgium, Poland, Peru
-
AstraZenecaRecruitingOvarian Cancer | Lung AdenocarcinomaUnited States, China, Spain, Canada, Australia, Taiwan, Israel, Japan, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Light Chain Deposition DiseaseUnited States, Puerto Rico, Ireland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingColorectal AdenocarcinomaUnited States, Puerto Rico
-
CelgeneActive, not recruiting
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Puerto Rico
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, HepatocellularColombia, Israel, Taiwan, United States, Australia, Brazil, Chile, China, Denmark, France, Germany, Hong Kong, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Norway, Portugal, Puerto Rico, Spain, Thailand, Turke... and more